The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma
Open accessAbstract
MicroRNA-155 (miR-155) is an oncogenic microRNA that regulates several pathways involved in cell division and immunoregulation. It is overexpressed in numerous cancers, is often correlated with poor prognosis, and is thus a key target for future therapies. In this work we show that overexpression of miR-155 in lymphoid tissues results in disseminated lymphoma characterized by a clonal, transplantable pre-B-cell population of neoplastic lymphocytes. Withdrawal of miR-155 in mice with established disease results in rapid regression of lymphadenopathy, in part because of apoptosis of the malignant lymphocytes, demonstrating that these tumors are dependent on miR-155 expression. We show that systemic delivery of antisense peptide nucleic acids encapsulated in unique polymer nanoparticles inhibits miR-155 and slows the growth of these “addicted” pre-B-cell tumors in vivo, suggesting a promising therapeutic option for lymphoma/leukemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
A microRNA expression signature of human solid tumors defines cancer gene targets
Volinia, S., Calin, G. A., Liu, C.-G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510565103 · Cited by 5,697
MicroRNA Gene Expression Deregulation in Human Breast Cancer
Iorio, M. V., Ferracin, M., Liu, C.-G., Veronese, A., Spizzo, R., Sabbioni, S., Magri, E., Pedriali, M., Fabbri, M., Campiglio, M., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1783 · Cited by 4,053
Silencing of microRNAs in vivo with ‘antagomirs’
Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., & Stoffel, M. (2005) · Nature · doi:10.1038/nature04303 · Cited by 3,949 · cited 3×
“While antagomirs and other chemically modified oligonucleotides can be effective anti-miRs, their utility in achieving miRNA inhibition in vivo may be limited without a delivery vehicle-when administered systemically, antagomirs show substantial targeting to the liver (32).”
BackgroundMethodUnique microRNA molecular profiles in lung cancer diagnosis and prognosis
Yanaihara, N., Caplen, N., Bowman, E., Seike, M., Kumamoto, K., Yi, M., Stephens, R. M., Okamoto, A., Yokota, J., Tanaka, T., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.01.025 · Cited by 3,023
Bushati, N., & Cohen, S. M. (2007) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.23.090506.123406 · Cited by 2,750
Koopman, G., Reutelingsperger, C., Kuijten, G., Keehnen, R., Pals, S., & van Oers, M. (1994) · Blood · doi:10.1182/blood.v84.5.1415.1415 · Cited by 2,681
Toxicity of cationic lipids and cationic polymers in gene delivery
Lv, H., Zhang, S., Wang, B., Cui, S., & Yan, J. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.04.014 · Cited by 2,286 · cited 1×
“In addition, although polycations are commonly exploited for nucleic acid delivery, because of their charge density, they may contribute adverse side effects in physiological and cellular environments (52).”
BackgroundMicroRNA-155 is induced during the macrophage inflammatory response
O'Connell, R. M., Taganov, K. D., Boldin, M. P., Cheng, G., & Baltimore, D. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610731104 · Cited by 1,866 · cited 1×
“Furthermore, miR155 induction in hematopoietic cells of myeloid origin results in a myeloproliferative pathology characterized by granulocyte/ monocyte expansion in lymphoid tissues (24, 25).”
BackgroundRequirement of bic/microRNA-155 for Normal Immune Function
Rodriguez, A., Vigorito, E., Clare, S., Warren, M. V., Couttet, P., Soond, D. R., van Dongen, S., Grocock, R. J., Das, P. P., Miska, E. A., et al. (2007) · Science · doi:10.1126/science.1139253 · Cited by 1,833
Regulation of the Germinal Center Response by MicroRNA-155
Thai, T.-H., Calado, D. P., Casola, S., Ansel, K. M., Xiao, C., Xue, Y., Murphy, A., Frendewey, D., Valenzuela, D., Kutok, J. L., et al. (2007) · Science · doi:10.1126/science.1141229 · Cited by 1,477
Accumulation of miR-155 and BIC RNA in human B cell lymphomas
Eis, P. S., Tam, W., Sun, L., Chadburn, A., Li, Z., Gomez, M. F., Lund, E., & Dahlberg, J. E. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500613102 · Cited by 1,325
Hardy, R. R., & Hayakawa, K. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.595 · Cited by 1,235
MicroRNA functions in animal development and human disease
Alvarez-Garcia, I., & Miska, E. A. (2005) · Development · doi:10.1242/dev.02073 · Cited by 1,104
MicroRNAs: new regulators of immune cell development and function
Baltimore, D., Boldin, M. P., O'Connell, R. M., Rao, D. S., & Taganov, K. D. (2008) · Nature Immunology · doi:10.1038/ni.f.209 · Cited by 1,088
OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma
Medina, P. P., Nolde, M., & Slack, F. J. (2010) · Nature · doi:10.1038/nature09284 · Cited by 1,073 · cited 3×
“To determine whether induction of miR-155 in various tissues is sufficient for tumorigenesis, we activated recombination in brain and lymphoid tissues by crossing these mice with a NesCre8 driver (30) to generate double heterozygote NesCre8; mir155LSLtTA mice, and withdrawing doxycycline from their chow at”
BackgroundMethodInfluentialSelf-citationCell Internalization of the Third Helix of the Antennapedia Homeodomain Is Receptor-independent
Derossi, D., Calvet, S., Trembleau, A., Brunissen, A., Chassaing, G., & Prochiantz, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.30.18188 · Cited by 1,073
Mechanisms and optimization of in vivo delivery of lipophilic siRNAs
Wolfrum, C., Shi, S., Jayaprakash, K. N., Jayaraman, M., Wang, G., Pandey, R. K., Rajeev, K. G., Nakayama, T., Charrise, K., Ndungo, E. M., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1339 · Cited by 974
Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in Eμ-miR155 transgenic mice
Costinean, S., Zanesi, N., Pekarsky, Y., Tili, E., Volinia, S., Heerema, N., & Croce, C. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602266103 · Cited by 951
Zambrowicz, B. P., Imamoto, A., Fiering, S., Herzenberg, L. A., Kerr, W. G., & Soriano, P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.3789 · Cited by 850
Inositol phosphatase SHIP1 is a primary target of miR-155
O'Connell, R. M., Chaudhuri, A. A., Rao, D. S., & Baltimore, D. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902636106 · Cited by 826
miR-155 gene: A typical multifunctional microRNA
Faraoni, I., Antonetti, F. R., Cardone, J., & Bonmassar, E. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.02.013 · Cited by 815
MicroRNA function in animal development
Wienholds, E., & Plasterk, R. H. A. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.07.070 · Cited by 813
microPrimer: the biogenesis and function of microRNA
Du, T., & Zamore, P. D. (2005) · Development · doi:10.1242/dev.02070 · Cited by 813
Weinstein, I. B., & Joe, A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-3293 · Cited by 805
Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model
Ma, L., Reinhardt, F., Pan, E., Soutschek, J., Bhat, B., Marcusson, E. G., Teruya-Feldstein, J., Bell, G. W., & Weinberg, R. A. (2010) · Nature Biotechnology · doi:10.1038/nbt.1618 · Cited by 772
Kluiver, J., Poppema, S., de Jong, D., Blokzijl, T., Harms, G., Jacobs, S., Kroesen, B., & van den Berg, A. (2005) · The Journal of Pathology · doi:10.1002/path.1825 · Cited by 672
A modeling analysis of the effects of molecular size and binding affinity on tumor targeting
Schmidt, M. M., & Wittrup, K. D. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0195 · Cited by 576
microRNA biogenesis and function in plants
Chen, X. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.07.071 · Cited by 567
Politi, K., Zakowski, M. F., Fan, P.-D., Schonfeld, E. A., Pao, W., & Varmus, H. E. (2006) · Genes & Development · doi:10.1101/gad.1417406 · Cited by 478
Dynamic regulation of miRNA expression in ordered stages of cellular development
Neilson, J. R., Zheng, G. X. Y., Burge, C. B., & Sharp, P. A. (2007) · Genes & Development · doi:10.1101/gad.1522907 · Cited by 471
Inflammation-induced tumorigenesis in the colon is regulated by caspase-1 and NLRC4
Hu, B., Elinav, E., Huber, S., Booth, C. J., Strowig, T., Jin, C., Eisenbarth, S. C., & Flavell, R. A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016814108 · Cited by 452
Self-citationOncogene addiction: setting the stage for molecularly targeted cancer therapy
Sharma, S. V., & Settleman, J. (2007) · Genes & Development · doi:10.1101/gad.1609907 · Cited by 441
Woodrow, K. A., Cu, Y., Booth, C. J., Saucier-Sawyer, J. K., Wood, M. J., & Mark Saltzman, W. (2009) · Nature Materials · doi:10.1038/nmat2444 · Cited by 438
Self-citationMicromanagement of the immune system by microRNAs
Lodish, H. F., Zhou, B., Liu, G., & Chen, C.-Z. (2008) · Nature Reviews Immunology · doi:10.1038/nri2252 · Cited by 438
Chemical modification and design of anti-miRNA oligonucleotides
Lennox, K. A., & Behlke, M. A. (2011) · Gene Therapy · doi:10.1038/gt.2011.100 · Cited by 433
Antagomir-17-5p Abolishes the Growth of Therapy-Resistant Neuroblastoma through p21 and BIM
Fontana, L., Fiori, M. E., Albini, S., Cifaldi, L., Giovinazzi, S., Forloni, M., Boldrini, R., Donfrancesco, A., Federici, V., Giacomini, P., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002236 · Cited by 385
Modulation of mismatch repair and genomic stability by miR-155
Valeri, N., Gasparini, P., Fabbri, M., Braconi, C., Veronese, A., Lovat, F., Adair, B., Vannini, I., Fanini, F., Bottoni, A., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002472107 · Cited by 349
Bethesda proposals for classification of lymphoid neoplasms in mice
Morse, H. C. (2002) · Blood · doi:10.1182/blood.v100.1.246 · Cited by 342
Liu, Q., Sasaki, T., Kozieradzki, I., Wakeham, A., Itie, A., Dumont, D. J., & Penninger, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.7.786 · Cited by 341
Origin of Chromosomal Translocations in Lymphoid Cancer
Nussenzweig, A., & Nussenzweig, M. C. (2010) · Cell · doi:10.1016/j.cell.2010.03.016 · Cited by 317
Costinean, S., Sandhu, S. K., Pedersen, I. M., Tili, E., Trotta, R., Perrotti, D., Ciarlariello, D., Neviani, P., Harb, J., Kauffman, L. R., et al. (2009) · Blood · doi:10.1182/blood-2009-05-220814 · Cited by 292
The monoclonality of human B-cell lymphomas.
Levy, R., Warnke, R., Dorfman, R. F., & Haimovich, J. (1977) · The Journal of experimental medicine · doi:10.1084/jem.145.4.1014 · Cited by 265
Inhibition of microRNA with antisense oligonucleotides
Esau, C. C. (2008) · Methods · doi:10.1016/j.ymeth.2007.11.001 · Cited by 257
Mutator activity induced by microRNA-155 ( miR-155 ) links inflammation and cancer
Tili, E., Michaille, J.-J., Wernicke, D., Alder, H., Costinean, S., Volinia, S., & Croce, C. M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1101795108 · Cited by 227
Ovcharenko, D., Kelnar, K., Johnson, C., Leng, N., & Brown, D. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1484 · Cited by 224
Efficient inhibition of miR-155 function in vivo by peptide nucleic acids
Fabani, M. M., Abreu-Goodger, C., Williams, D., Lyons, P. A., Torres, A. G., Smith, K. G. C., Enright, A. J., Gait, M. J., & Vigorito, E. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq160 · Cited by 214
Lack of BIC and microRNA miR‐155 expression in primary cases of Burkitt lymphoma
Kluiver, J., Haralambieva, E., de Jong, D., Blokzijl, T., Jacobs, S., Kroesen, B., Poppema, S., & van den Berg, A. (2006) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.20273 · Cited by 214
Onco‐miR‐155 targets SHIP1 to promote TNFα‐dependent growth of B cell lymphomas
Pedersen, I. M., Otero, D., Kao, E., Miletic, A. V., Hother, C., Ralfkiaer, E., Rickert, R. C., Gronbaek, K., & David, M. (2009) · EMBO Molecular Medicine · doi:10.1002/emmm.200900028 · Cited by 209
Potent inhibition of microRNA in vivo without degradation
Davis, S., Propp, S., Freier, S. M., Jones, L. E., Serra, M. J., Kinberger, G., Bhat, B., Swayze, E. E., Bennett, C. F., & Esau, C. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn904 · Cited by 200
MicroRNA function in neuronal development, plasticity and disease
Fiore, R., Siegel, G., & Schratt, G. (2008) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2007.12.006 · Cited by 199
Liu, L., Damen, J. E., Hughes, M. R., Babić, I., Jirik, F. R., & Krystal, G. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.14.8983 · Cited by 135
Beletsi, A., Panagi, Z., & Avgoustakis, K. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.03.024 · Cited by 128
Cheng, C. J., & Saltzman, W. M. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.04.053 · Cited by 128
Self-citationMicroRNA-155 Function in B Cells
Calame, K. L. (2007) · Immunity · doi:10.1016/j.immuni.2007.11.010 · Cited by 124
miR‐155/BIC as an oncogenic microRNA
Tam, W., & Dahlberg, J. E. (2005) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20282 · Cited by 113
miRNA Modulation of the Cellular Stress Response
Babar, I., Slack, F. J., & Weidhaas, J. B. (2008) · Future Oncology · doi:10.2217/14796694.4.2.289 · Cited by 112
Self-citationMcNeer, N. A., Chin, J., Schleifman, E., Fields, R. J., Glazer, P. M., & Saltzman, W. M. (2010) · Molecular Therapy · doi:10.1038/mt.2010.200 · Cited by 100
Self-citationEnumeration and characterization of DJH structures in mouse fetal liver.
Chang, Y., Paige, C. J., & Wu, G. E. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05241.x · Cited by 96
Silencing microRNA by interfering nanoparticles in mice
Su, J., Baigude, H., McCarroll, J. A., & Rana, T. M. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1307 · Cited by 71
An ES cell system for rapid, spatial and temporal analysis of gene function in vitro and in vivo
Mao, J. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni146 · Cited by 47
High frequency of normal DJH joints in B cell progenitors in severe combined immunodeficiency mice.
Pennycook, J. L. M. H., Chang, Y., Celler, J. W., Phillips, R. A., & Wu, G. E. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.178.3.1007 · Cited by 32
Reversal of HIV-1 latency with anti-microRNA inhibitors
Zhang, H. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.07.016 · Cited by 29
Boer, A. J. M. D. J.-D., Drayer, A. L., & Vellenga, E. (2001) · Leukemia · doi:10.1038/sj.leu.2402261 · Cited by 25
Cited by
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
Rupaimoole, R., & Slack, F. J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.246 · Cited by 4,741
Non-coding RNA networks in cancer
Anastasiadou, E., Jacob, L. S., & Slack, F. J. (2018) · Nature Reviews Cancer · doi:10.1038/nrc.2017.99 · Cited by 1,884
Self-citationThe role of non-coding RNAs in oncology
Slack, F. J., & Chinnaiyan, A. M. (2019) · Cell · doi:10.1016/j.cell.2019.10.017 · Cited by 1,619
Self-citationMicroRNA: Function, Detection, and Bioanalysis
Dong, H., Lei, J., Ding, L., Wen, Y., Ju, H., & Zhang, X. (2013) · Chemical Reviews · doi:10.1021/cr300362f · Cited by 1,224
Jansson, M. D., & Lund, A. H. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.09.006 · Cited by 1,099
Metadata
- Authors
- Babar, I. A., Cheng, C. J., Booth, C. J., Liang, X., Weidhaas, J. B., Saltzman, W. M., & Slack, F. J.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2012-06-08
- Volume
- 109
- Issue
- 26
- Pages
- E1695-704
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2125071715
- Cited by
- 497
- References
- 66
- FWCI
- 18.70
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.